The global landscape for anxiety treatment is undergoing a radical shift as the market reaches an estimated value of $15.8 billion. For decades, patients often cycled through multiple medications before finding relief, but 2026 marks the rise of biomarker-guided therapy and genetic profiling. Pharmaceutical developers are increasingly leveraging these tools to tailor treatment regimens,...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt